BioCentury | Feb 26, 2021
Distillery Therapeutics

Antibody-drug conjugate targeting CLDN6 for liver cancer

...Sci. Transl. Med.; published online Feb. 3, 2021doi:10.1126/scitranslmed.abb6282CONTACT: Ming Liu, Guangzhou Medical University, Guangzhou, Chinaemail: liuming@gzhmu.edu.cn CONTACT: Mao-Bin...
BioCentury | Oct 8, 2020
Product Development

Mapping opportunities for China’s early cancer detection boom

...“If the government realizes it wants to do something, it does it at population scale.” Mao...
...to do something, it does it at population scale,” said SeekIn Inc. founder and CEO Mao...
...data on their performance. Following the “small-scale” launch of its multicancer blood test in 2018, Mao...
BioCentury | Jul 31, 2020
Distillery Therapeutics

MAO-B, GABRA5 identified as astrocyte targets in subcortical stroke

...an shRNA targeting MAO-B in astrocytes restored glucose metabolism and decreased cortical diaschisis volume. Astrocyte-specific MAO-B...
...effects of MAO-B inhibition were mediated by reductions in GABA production. In the model, the MAO-B...
...GABRA5, in Phase II testing for severe motor impairment following ischemic stroke. TARGET/MARKER/PATHWAY: Monoamine oxidase B (MAO-B...
BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...LLC (Palm Beach Gardens, Fla.) hired Li Mao as CEO, succeeding interim CEO Chris Liang. Mao...
BioCentury | Mar 22, 2019
Financial News

CanSino could get $598M valuation in Hong Kong IPO

...Chairman and CEO Xuefeng Yu, CSO Tao Zhu, SVP Dongxu Qiu and SVP Helen Huihua Mao...
BioCentury | Oct 25, 2018
Translation in Brief

Big debuts for big genomics

...purpose was to add additional value to that data,” said BGI CSO and study co-author Mao...
...describe in the Cell study. “We could use one stone to kill three birds,” said Mao...
...population, creating a baseline for cancer tests, and to monitor NIPT samples for viral outbreaks. Mao...
BioCentury | Oct 11, 2018
Strategy

Border security for China’s genomes

...exploitation by foreign entities. “The notion is that genetic data is a national treasure,” said Mao...
...between the U.S. and China. “The notion is that genetic data is a national treasure.” Mao...
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...participation in the Human Genome Project in the late 1990s, according to BGI Genomics CSO Mao...
...China, suddenly genomics was ranked much higher than other subjects like physics and chemistry,” said Mao...
...early movers, including former BGI CEO Jun Wang, who founded digital health company iCarbonX and Mao...
BioCentury | Aug 23, 2018
Distillery Therapeutics

Neurology

...AD. Neurim Pharmaceuticals Ltd. has Neu-120, a selective uncompetitive NMDA receptor modulator and monoamine oxidase B (MAO-B...
BioCentury | Jul 20, 2018
Financial News

CanSino latest to file for HKEX IPO

...and CSO Tao Zhu; co-founder and SVP Dongxu Qiu; and co-founder and SVP Helen Huihua Mao...
Items per page:
1 - 10 of 317